XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Preferred Stock
Preferred Stock Class A
Preferred Stock
Preferred Stock Class B
Common stock subscriptions
Additional Paid in Capital.
Accumulated Deficit
Total
Balance at beginning at Sep. 30, 2020 $ 11,432 $ 3 $ 20 $ 135,144 $ 36,669,899 $ (35,867,920) $ 948,578
Balance at beginning (in shares) at Sep. 30, 2020 114,320,911 30,667 200,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Shares issued for cash $ 75       899,925   900,000
Shares issued for cash (in shares) 757,333            
Cash received for common stock subscribed       330,000     330,000
Issuance of common stock subscribed $ (5)     20,000 (19,995)    
Issuance of common stock subscribed (in shares) (53,333)            
Shares issued in connection with reverse merger         (1)   (1)
Shares issued for asset purchase $ 137       2,671,096   2,671,233
Shares issued for asset purchase (in shares) 1,369,863            
Beneficial conversion feature of convertible debenture         750,000   750,000
Stock-based compensation         134,253   134,253
Warrants issued to consultants         492,000   492,000
Shares issued for debt settlement $ 10       194,793   194,803
Shares issued for debt settlement (in shares) 97,891            
Shares issued for license content asset $ 118       2,065,878   2,065,996
Shares issued for license content asset (in shares) 1,180,880            
Shares issued for equity investment in unconsolidated entity $ 46       863,434   863,480
Shares issued for equity investment in unconsolidated entity (in shares) 454,463            
Net loss           (5,676,224) (5,676,224)
Balance at ending at Dec. 31, 2020 $ 11,813 $ 3 $ 20 485,144 44,721,282 (41,544,144) 3,674,118
Balance at ending (in shares) at Dec. 31, 2020 118,128,008 30,667 200,000        
Balance at beginning at Sep. 30, 2020 $ 11,432 $ 3 $ 20 135,144 36,669,899 (35,867,920) $ 948,578
Balance at beginning (in shares) at Sep. 30, 2020 114,320,911 30,667 200,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Shares issued for cash (in shares)             3,228,000
Shares issued for debt settlement             $ 194,803
Shares issued for debt settlement (in shares)             97,891
Net loss             $ (17,847,682)
Balance at ending at Jun. 30, 2021 $ 12,732   $ 20   63,853,146 (53,715,602) 10,150,296
Balance at ending (in shares) at Jun. 30, 2021 127,316,716   200,000        
Balance at beginning at Dec. 31, 2020 $ 11,813 $ 3 $ 20 485,144 44,721,282 (41,544,144) 3,674,118
Balance at beginning (in shares) at Dec. 31, 2020 118,128,008 30,667 200,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of common stock subscribed $ 49     $ (485,144) 485,095    
Issuance of common stock subscribed (in shares) 497,429            
Beneficial conversion feature of convertible debenture         306,346   306,346
Stock-based compensation         5,419,800   5,419,800
Conversion of convertible debenture $ 100       376,256   376,356
Conversion of convertible debenture (in shares) 1,003,618            
Warrants issued in conjunction with debenture         43,654   43,654
Shares issued for cash $ 156       1,954,844   1,955,000
Shares issued for cash (in shares) 1,564,000            
Net loss           (8,247,115) (8,247,115)
Balance at ending at Mar. 31, 2021 $ 12,118 $ 3 $ 20   53,307,277 (49,791,259) 3,528,159
Balance at ending (in shares) at Mar. 31, 2021 121,193,055 30,667 200,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Beneficial conversion feature of convertible debenture         1,705,709   1,705,709
Stock-based compensation         1,482,746   1,482,746
Warrants issued in conjunction with debenture         144,291   144,291
Shares issued for acquisition $ 200       5,689,555   5,689,755
Shares issued for acquisition (in shares) 2,003,435            
Warrants issued for severance         82,000   82,000
Shares issued for cash $ 96       1,199,904   1,200,000
Shares issued for cash (in shares) 960,000            
Payment in kind interest stock issuance $ 3       41,976   41,979
Payment in kind interest stock issuance (in shares) 14,475            
Shares issued for consulting fees $ 8       199,992   200,000
Shares issued for consulting fees (in shares) 79,051            
Conversion of series convertible stock to common stock $ 307 $ (3)     (304)    
Conversion of series convertible stock to common stock (in shares) 3,066,700 (30,667)          
Net loss           (3,924,343) (3,924,343)
Balance at ending at Jun. 30, 2021 $ 12,732   $ 20   63,853,146 (53,715,602) 10,150,296
Balance at ending (in shares) at Jun. 30, 2021 127,316,716   200,000        
Balance at beginning at Sep. 30, 2021 $ 13,345   $ 20   69,824,754 (66,842,416) 2,995,703
Balance at beginning (in shares) at Sep. 30, 2021 133,470,018   200,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation         1,549,406   1,549,406
Net loss           (4,273,995) (4,273,995)
Balance at ending at Dec. 31, 2021 $ 13,345   $ 20   71,374,160 (71,116,411) 271,114
Balance at ending (in shares) at Dec. 31, 2021 133,470,018   200,000        
Balance at beginning at Sep. 30, 2021 $ 13,345   $ 20   69,824,754 (66,842,416) 2,995,703
Balance at beginning (in shares) at Sep. 30, 2021 133,470,018   200,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Payment in kind interest stock issuance $ 177,000           (177,000)
Payment in kind interest stock issuance (in shares) 69,455            
Net loss             (14,921,110)
Balance at ending at Jun. 30, 2022 $ 15,352       79,319,016 (81,763,526) (2,429,158)
Balance at ending (in shares) at Jun. 30, 2022 153,539,473            
Balance at beginning at Dec. 31, 2021 $ 13,345   $ 20   71,374,160 (71,116,411) 271,114
Balance at beginning (in shares) at Dec. 31, 2021 133,470,018   200,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation         1,116,318   1,116,318
Warrants issued to consultants         56,788   56,788
Payment in kind interest stock issuance $ 4       88,496   88,500
Payment in kind interest stock issuance (in shares) 37,136            
Conversion of series convertible stock to common stock $ 2,000   $ (20)   (1,980)    
Conversion of series convertible stock to common stock (in shares) 20,000,000   (200,000)        
Net loss           (4,974,830) (4,974,830)
Balance at ending at Mar. 31, 2022 $ 15,349       72,633,782 (76,091,241) (3,442,110)
Balance at ending (in shares) at Mar. 31, 2022 153,507,154            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock-based compensation         1,282,548   1,282,548
Warrants issued to consultants         197,226   197,226
Warrants issued in conjunction with debenture         3,036,970   3,036,970
Early extinguishment of convertible debt         $ 2,079,993   $ 2,079,993
Payment in kind interest stock issuance $ 3            
Payment in kind interest stock issuance (in shares) 32,319       88,497   88,500
Net loss           (5,672,285) $ (5,672,285)
Balance at ending at Jun. 30, 2022 $ 15,352       $ 79,319,016 $ (81,763,526) $ (2,429,158)
Balance at ending (in shares) at Jun. 30, 2022 153,539,473